From the *Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center; †Medical Clinic V, University Hospital Heidelberg; ‡National Center for Tumor Diseases Heidelberg; §Department of Radiology, German Cancer Research Center; and ║Division of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany.
Clin Nucl Med. 2015 Jun;40(6):e300-7. doi: 10.1097/RLU.0000000000000773.
The value of F-FDG PET in the diagnostic approach of multiple myeloma (MM) remains incompletely elicited. Little is known about the kinetics of F-FDG in the bone marrow and extramedullary sites in MM. This study aimed to evaluate quantitative data on kinetics and distribution patterns of F-FDG in MM patients with regard to pelvic bone marrow plasma cell infiltration.
The study included 40 patients with primary MM. Dynamic PET/CT scanning of the lower lumbar spine and pelvis was performed after the administration of F-FDG. Whole-body PET/CT studies were performed. Sites of focal increased tracer uptake were considered as highly suggestive of myelomatous involvement after taking into account the patient history and CT findings. Bone marrow of the os ilium without pathologic tracer accumulation served as reference. The evaluation of dynamic PET/CT studies was based in addition to the conventional visual (qualitative) assessment, on semiquantitative (SUV) calculations, as well as on absolute quantitative estimations after application of a 2-tissue compartment model and a noncompartmental approach. F-FDG quantitative information and corresponding distribution patterns were correlated with pelvic bone marrow plasma cell infiltration.
Fifty-two myelomatous lesions were detected in the pelvis. All parameters in suspected MM lesions ranged in significantly higher levels than in reference tissue (P < 0.01). Correlative analyses revealed that bone marrow plasma cell infiltration rate correlated significantly with SUVaverage, SUVmax, and the parameters K1, influx, and fractal dimension of F-FDG in reference bone marrow (P < 0.01). In addition, whole-body static PET/CT imaging demonstrated 4 patterns of tracer uptake; these are as follows: negative, focal, diffuse, and mixed (focal/diffuse) tracer uptake. Patients with a mixed pattern of radiotracer uptake had the highest mean plasma cell infiltration rate in their bone marrow, whereas those with negative PET/CT scans demonstrated the lowest bone marrow plasma cell infiltration. In total, 265 focal myeloma-indicative F-FDG-avid lesions were detected, 129 of which correlated with low-dose CT osteolytic findings. No significant correlation between the number of focal lesions detected in PET/CT and bone marrow infiltration was detected.
The F-FDG kinetic parameters K1, influx, and fractal dimension as well as SUVaverage from reference tissue correlated significantly with bone marrow malignant plasma cell infiltration rate. Patients with negative PET/CT demonstrated the lowest bone marrow infiltration by malignant plasma cells, whereas those with a mixed pattern of tracer uptake had the highest infiltration.
正电子发射断层扫描(PET)-氟代脱氧葡萄糖(FDG)在多发性骨髓瘤(MM)诊断方法中的价值仍不完全明确。关于 MM 患者骨髓外部位 FDG 的动力学,我们知之甚少。本研究旨在评估定量数据,以了解与骨盆骨髓浆细胞浸润相关的 MM 患者 FDG 的动力学和分布模式。
本研究纳入 40 例原发性 MM 患者。在给予 FDG 后,对下腰椎和骨盆进行动态 PET/CT 扫描。进行全身 PET/CT 检查。考虑到患者病史和 CT 发现,将放射性示踪剂摄取增加的局灶性部位视为骨髓瘤受累的高度提示。无病理性示踪剂积聚的髂骨骨髓作为参考。除了常规的视觉(定性)评估外,还基于半定量(SUV)计算以及应用双室模型和非房室模型进行的绝对定量估计,对动态 PET/CT 研究进行评估。FDG 定量信息和相应的分布模式与骨盆骨髓浆细胞浸润相关。
在骨盆中检测到 52 个骨髓瘤病变。疑似 MM 病变的所有参数均明显高于参考组织(P<0.01)。相关分析显示,骨髓浆细胞浸润率与参考骨髓中 FDG 的 SUVaverage、SUVmax、K1、流入和分形维数等参数显著相关(P<0.01)。此外,全身静态 PET/CT 成像显示示踪剂摄取有 4 种模式;分别为:阴性、局灶性、弥漫性和混合(局灶性/弥漫性)摄取。混合摄取模式的患者骨髓浆细胞浸润率最高,而 PET/CT 扫描阴性的患者骨髓浆细胞浸润率最低。总共检测到 265 个局灶性提示骨髓瘤的 FDG 摄取病灶,其中 129 个与低剂量 CT 溶骨性发现相关。PET/CT 检测到的局灶性病变数量与骨髓浸润之间无显著相关性。
参考组织的 FDG 动力学参数 K1、流入和分形维数以及 SUVaverage 与骨髓恶性浆细胞浸润率显著相关。PET/CT 阴性的患者骨髓恶性浆细胞浸润率最低,而混合摄取模式的患者浸润率最高。